NCGI
CSTL icon

Next Century Growth Investors’s Castle Biosciences CSTL Stock Holding History

Next Century Growth Investors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-235,214
Closed -$6.27M – 126
2024
Q4 		$6.27M Buy
235,214
+1,123
+0.5% +$34.2K 0.47% 78
2024
Q3 		$6.68M Sell
234,091
-2,739
-1% -$69.7K 0.54% 60
2024
Q2 		$5.16M Buy
236,830
+17,357
+8% +$387K 0.43% 65
2024
Q1 		$4.86M Buy
219,473
+5,587
+3% +$122K 0.42% 67
2023
Q4 		$4.62M Buy
+213,886
New +$3.76M 0.45% 62
2022
Q2 		– Sell
-538,673
Closed -$24.2M – 117
2022
Q1 		$24.2M Buy
538,673
+230,829
+75% +$9.54M 2.41% 10
2021
Q4 		$13.2M Buy
307,844
+32,402
+12% +$1.69M 1.19% 31
2021
Q3 		$18.3M Sell
275,442
-6,353
-2% -$447K 1.59% 19
2021
Q2 		$20.7M Sell
281,795
-36,644
-12% -$2.42M 1.61% 16
2021
Q1 		$21.8M Sell
318,439
-32,370
-9% -$2.43M 1.66% 17
2020
Q4 		$23.6M Buy
350,809
+75,155
+27% +$4.07M 1.99% 11
2020
Q3 		$14.2M Buy
275,654
+61,729
+29% +$2.75M 1.48% 18
2020
Q2 		$8.06M Buy
213,925
+126,104
+144% +$4.31M 0.92% 42
2020
Q1 		$2.62M Buy
+87,821
New +$2.65M 0.42% 76

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Next Century Growth Investors's CSTL Position: Q1 2025 in Review

Next Century Growth Investors sold out of Castle Biosciences (CSTL) in Q1 2025, closing a stake of 235,214 shares — an estimated $6.27M sold.

Next Century Growth Investors first reported a position in CSTL in Q1 2020 and held it in 14 quarters. The position peaked at $24.2M in Q1 2022. 180 funds tracked by Wall St. Rank hold CSTL as of Q1 2025.

  • Next Century Growth Investors reported no remaining Castle Biosciences position as of Q1 2025 after selling out during the quarter.
  • Next Century Growth Investors sold 235,214 Castle Biosciences shares in Q1 2025, an estimated $6.27M.
  • Next Century Growth Investors first reported a position in Castle Biosciences in Q1 2020 and held it in 14 quarters.
  • Next Century Growth Investors's Castle Biosciences position peaked at $24.2M in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2025.

Based on Next Century Growth Investors's 13F filing for Q1 2025, filed 14 May 2025.